Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2019.Jun.27

Announcement on Re-election of Board of Directors at the 2019 Annual General Meeting

2019.Jun.27

Announcement of Resolution Items from 2019 Annual General Meeting

2019.Jun.24

Clarification on the news article by internet media on Jun 21,2019

2019.Jun.21

Company Chairman Mr. Michael Chang and other five executives received an acquittal for insider trading case by Taiwan Shilin District Court

2019.Jun.17

Clarification on new article by Economy Daily News dated Jun 16, 2019

2019.Jun.15

OBI-888 completes Phase I safety evaluation and demonstrates its safety and tolerability with no major concerns

2019.Jun.14

Announcement of the company's cash capital increase and base date

2019.Jun.10

Board of directors of the company waived subscription rights exceeding half of the total subscribable shares. Shares to be subscribed by designated persons

2019.May.06

Letter received from National Medical Products Administration (NMPA) of China regarding Adagloxad Simolenin (OBI-822) Phase III clinical study to be resubmitted after supplementation

2019.Apr.22

Supplementary announcement for the company to issue ordinary shares through rights offering

News

Latest News

Events

Latest events